Row over Curie building ends on a high note

Michael Francisco

DOI: https://doi.org/10.1038/s41587-024-02140-3

IF: 46.9

2024-02-16

Nature Biotechnology

Abstract:Nature Biotechnology, Published online: 15 February 2024; doi:10.1038/s41587-024-02140-3 Row over Curie building ends on a high note

biotechnology & applied microbiology

What problem does this paper attempt to address?

A New Horizon in Engineering: Introducing Chem & Bio Engineering

Qilong Ren

DOI: https://doi.org/10.1021/cbe.4c00023

2024-01-01

Abstract:ADVERTISEMENT RETURN TO ISSUEEditorialNEXTA New Horizon in Engineering: Introducing Chem & Bio EngineeringQilong RenQilong RenZhejiang University, Hangzhou 310027, ChinaMore by Qilong RenCite this: Chem Bio Eng. 2024, 1, 1, 1Publication Date (Web):February 22, 2024Publication History Received25 January 2024Published online22 February 2024Published inissue 22 February 2024https://doi.org/10.1021/cbe.4c00023Zhejiang University and American Chemical Society. Co-published 2024 by Zhejiang University and American Chemical Society. This publication is licensed under CC-BY-NC-ND 4.0. License Summary*You are free to share (copy and redistribute) this article in any medium or format within the parameters below:Creative Commons (CC): This is a Creative Commons license.Attribution (BY): Credit must be given to the creator.Non-Commercial (NC): Only non-commercial uses of the work are permitted. No Derivatives (ND): Derivative works may be created for non-commercial purposes, but sharing is prohibited. View full license*DisclaimerThis summary highlights only some of the key features and terms of the actual license. It is not a license and has no legal value. Carefully review the actual license before using these materials. This publication is Open Access under the license indicated. Learn MoreArticle Views-Altmetric-Citations-LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (1 MB) Get e-AlertscloseSUBJECTS:Bioengineering and biotechnology,Chemical engineering and industrial chemistry,Green chemistry,Manufacturing,Nanomedicine Get e-Alerts
Biotech news from around the world

DOI: https://doi.org/10.1038/s41587-022-01458-0

IF: 46.9

2022-09-10

Nature Biotechnology

Abstract:Nature Biotechnology, Published online: 09 September 2022; doi:10.1038/s41587-022-01458-0 Biotech news from around the world

biotechnology & applied microbiology
Biotechnology and Bioengineering: Volume 112, Number 8, August 2015

Hanna Kim,Kitty Siu,M Raeeszadeh-Sarmazdeh,Qian Sun,Qing Chen,Weihong Chen,Éric Ouellet,Joe P. Foley,E. J. Conway,Christy L. Haynes,N. A. Khan,S. Eric Nybo,Joseph Chappell,Wayne R. Curtis,Amanda Hawkins,Huiwen Lian,Benjamin M. Zeldes,Andrew J. Loder,Gary H. Lipscomb,Gerrit J. Schut,Mary Keller,Megan Adams,R Kelly,Thomas Worley‐Morse,Marc A. Deshusses,C Gunsch Bioseparations,Arthur A. Noyes,Ben Huffman,Ranga Godavarti,Nigel J. Titchener‐Hooker,Jay D. Coffman,Khurram Sunasara,Tarit Mukhopadhyay,Alex Berrill,N. Merchant,Taekjip Ha,Youdan Kim,Gloria Lee,Frederik De Bruyn,Boél De Paepe,Julie Maertens,Joeri Beauprez,Pieter De Cocker,Stein Mincke,Charles F. Stevens,Marjan De Mey,Hyun‐Jun Jang,Bruce Ha,Jian Zhou,Jungkyu Ahn,San-Hyun Yoon,S.-W Kim,Weili Jiang,Yi-Rong Jiang,Gill Bentley,Daniel Liu,Yuhang Xiao,Fusuo Zhang,D. Li,Hyonkwang Choi,Soyun Cho,Sarah Jeong,Zhendong Jin,C Lee,Sun Young Ko,Jin‐Woo Park,Soo-Hyun Park,Atanu Bhattacharjee,Choi Jeong-Wha,Ali Motlagh,Suresh K. Mukherji,Ramesh Goel,Yonatan Chemla,Eden Ozer,Orr Schlesinger,Vincent Noireaux,Lital Alfonta,Paul Anand,Albert S. Fu,Say Yen Teoh,Kun Luo,Thomas R.J. Heathman,Veronica A. M. Glyn,Andrew Picken,Q Rafi,Karen Coopman,Alvin W. Nienow,Bo Kara,Christopher J. Hewitt,Thomas Imhof,Nora Gruenewald,Gerhard Schwarz,Michael Noack,M Koch Bioseparations,Steven Branston,John D. Wright,Eli Keshavarz‐Moore,Hong Wu,Gary W. Bennett,Ka‐Yiu San

DOI: https://doi.org/10.1002/bit.25415

IF: 3.8

2015-01-01

Biotechnology and Bioengineering

Abstract:Biotechnology and BioengineeringVolume 112, Issue 8 p. fmi-fmv ContentsFree Access Biotechnology and Bioengineering: Volume 112, Number 8, August 2015 First published: 25 June 2015 https://doi.org/10.1002/bit.25415AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Volume112, Issue8August 2015Pages fmi-fmv RelatedInformation
The Ever-Expanding Boundaries of Synthetic Biology.

Huimin Zhao

DOI: https://doi.org/10.1021/acssynbio.2c00582

IF: 5.249

2022-01-01

ACS Synthetic Biology

Abstract:ADVERTISEMENT RETURN TO ISSUEEditorialNEXTThe Ever-Expanding Boundaries of Synthetic BiologyHuimin Zhao*Huimin ZhaoDepartment of Chemical and Biomolecular Engineering, University of Illinois at Urbana−Champaign, Urbana, Illinois 61801, United States*Email: [email protected]More by Huimin ZhaoCite this: ACS Synth. Biol. 2022, 11, 11, 3550Publication Date (Web):November 18, 2022Publication History Published online18 November 2022Published inissue 18 November 2022https://pubs.acs.org/doi/10.1021/acssynbio.2c00582https://doi.org/10.1021/acssynbio.2c00582editorialACS PublicationsCopyright © 2022 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views1396Altmetric-Citations-LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (798 KB) Get e-AlertscloseSUBJECTS:Carbon capture and storage,Cells,Gene therapy,Genetics,Synthetic biology Get e-Alerts
Sanofi- Cell Research outstanding paper award of 2023

Cell Research Editorial Team

DOI: https://doi.org/10.1038/s41422-024-01056-6

IF: 44.1

2024-11-28

Cell Research

Abstract:Cell Research, Published online: 26 November 2024; doi:10.1038/s41422-024-01056-6 Sanofi- Cell Research outstanding paper award of 2023

cell biology
Single-cell biology: what does the future hold?

Maria Polychronidou,Jingyi Hou,M Madan Babu,Prisca Liberali,Ido Amit,Bart Deplancke,Galit Lahav,Shalev Itzkovitz,Matthias Mann,Julio Saez-Rodriguez,Fabian Theis,Roland Eils

DOI: https://doi.org/10.15252/msb.202311799

IF: 13.068

2023-01-01

Molecular Systems Biology

Abstract:In this Editorial, our Chief Editor and members of our Advisory Editorial Board discuss recent breakthroughs, current challenges, and emerging opportunities in single-cell biology and share their vision of "where the field is headed."
CRISPR Nobelists surrender their own European patents

Charlotte Harrison

DOI: https://doi.org/10.1038/s41587-024-02472-0

IF: 46.9

2024-11-05

Nature Biotechnology

Abstract:A strategic move by lawyers acting for Doudna and Charpentier is the latest twist in the battleground for CRISPR–Cas9 technology.

biotechnology & applied microbiology
Erratum: Nature Biotechnology's academic spinouts of 2017

Malorye Allison Branca,Ken Garber,Laura DeFrancesco

DOI: https://doi.org/10.1038/nbt0818-772c

IF: 46.9

2018-08-06

Nature Biotechnology

Abstract:Nat. Biotechnol. 36, 297–306 (2018); published online 5 April 2018; corrected after print 15 May 2018 In the version of this article initially published, the name and photo of Viviane Tabar, one of BlueRock's founders, was omitted. A misplaced '&' in the author list in the PDF has been corrected, and the abbreviation MSKCC added in the text.

biotechnology & applied microbiology
Chemistry Nobel Honors CRISPR, an "Essential" Tool for Cancer.

DOI: https://doi.org/10.1158/2159-8290.CD-NB2020-090

IF: 28.2

2020-10-09

Cancer Discovery

Abstract:Emmanuelle Charpentier, PhD, and Jennifer Doudna, PhD, who pioneered the site-specific CRISPR gene-editing technology that has revolutionized cancer research and treatment, were awarded the 2020 Nobel Prize in Chemistry. Many CRISPR-based therapies are already in human testing, with gene-edited T cells for blood cancers and solid tumors leading the way.

Medicine,Chemistry
Biotechnology Patent Law Top Ten of 2022: Inducement, Clear Error, and Interferences Galore

Kevin E. Noonan,Andrew W. Torrance

DOI: https://doi.org/10.25172/smustlr.26.2.5

2023-01-01

Abstract:Five-year anniversaries are symbolized by a product of natural biotechnology: wood. This article marks the wood anniversary of the “Top Ten Biotechnology Patent Cases” series that began in 2018. Imagining the world in 2018 is challenging, in part because it was, indeed, a different world. There had not been a major pandemic in one hundred years. Inflation was low. The economy hummed along. No individual war appeared to threaten more than regional stability. O tempora, o mores! The year 2022 was quite different. SARS-CoV-2 continued to stalk the land, having had a monumentally mortiferous effect for several years. High inflation was rampant. The economy was still recovering from one of the deepest declines in history, with imbalances across many sectors. Moreover, eastern Europe had let slip the dogs of war, threatening peace worldwide. Biotechnology also has seen changes of significant magnitude. Venture capital investment in biotechnology was small compared to what it is now. Efficient genome editing was restricted to first-generation CRISPR-Cas9 systems, while now it may be accomplished using more powerful and accurate methods, like base editing and prime editing (the latter offering hope for treatment in almost 90% of genetic diseases). Courts had declared that diagnostic methods did not constitute patentable subject matter, which remains the case today, although clever draftswomen continue their efforts to obtain claims protecting such methods to some extent. Over the course of 2022, courts decided a generous selection of cases covering a wide variety of biotechnology patent law issues. These cases ran the gamut, from patent doctrines concerning satisfaction of the written description requirement for antibody claims to mechanisms for augmenting patent terms using either Patent Term Extension, or Patent Term Adjustment, or both. This article has chosen ten of the most important, though, as is the case every year, our choice of only ten was difficult, and, by necessity, left worthy cases on the cutting room floor.
Editor's pick: Tome Biosciences

Charles Schmidt

DOI: https://doi.org/10.1038/s41587-024-02280-6

IF: 46.9

2024-06-20

Nature Biotechnology

Abstract:Each year, Nature Biotechnology highlights companies that have received sizeable early-stage funding in the previous year. Tome Biosciences inserts large DNA sequences into precise genomic locations, overcoming limitations of base and prime editing.

biotechnology & applied microbiology
What Will We Carry Forward from This Time?

Samuel Chigome,Chennupati Jagadish,Cherie R. Kagan,Ajay Sood,Haixia Zhang,Paul S. Weiss

DOI: https://doi.org/10.1021/acsnano.0c09507

IF: 17.1

2020-01-01

ACS Nano

Abstract:ADVERTISEMENT RETURN TO ISSUEEditorialNEXTWhat Will We Carry Forward from This Time?Samuel ChigomeSamuel ChigomeMore by Samuel Chigomehttp://orcid.org/0000-0002-6196-8467, Chennupati JagadishChennupati JagadishMore by Chennupati Jagadishhttp://orcid.org/0000-0003-1528-9479, Cherie R. KaganCherie R. KaganMore by Cherie R. Kaganhttp://orcid.org/0000-0001-6540-2009, Ajay SoodAjay SoodMore by Ajay Soodhttp://orcid.org/0000-0002-4157-361X, Haixia ZhangHaixia ZhangMore by Haixia Zhanghttp://orcid.org/0000-0003-4565-4123, and Paul S. Weiss*Paul S. Weiss*Email: [email protected]More by Paul S. Weisshttp://orcid.org/0000-0001-5527-6248Cite this: ACS Nano 2020, 14, 11, 14253–14254Publication Date (Web):November 24, 2020Publication History Published online24 November 2020Published inissue 24 November 2020https://pubs.acs.org/doi/10.1021/acsnano.0c09507https://doi.org/10.1021/acsnano.0c09507editorialACS PublicationsCopyright © 2020 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views1615Altmetric-Citations4LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (790 KB) Get e-AlertscloseSUBJECTS:Biology,Isolation,Materials science,Safety Get e-Alerts
Biotechnology and Bioengineering: Volume 120, Number 2, February 2023

Laura Colomina‐Alfaro,Silvia Marchesan,Artemis Stamboulis,Antonella Bandiera,Anurag S. Rathore,Garima Thakur,Nikhil Kateja,Shalu Aggarwal,Saiqa Articles,Ming Lei,Vikas Trivedi,Nikhil U. Nair,Kyongbum Lee,James A. Van Deventer,María Florencia,Gustavo Soriano Pignataro,F. Gordo,Martín Tejedor Fernández,G. H. Taboada Hernán,Fernando Gentili,Javier Battaglini,Hongxiang Yan,Mark S. Wigmosta,Michael H. Huesemann,Ning Sun,Song Gao,Yusheng Li,Bingbing Li,Tian,Han-Qing Yu,Stine Christ,Lars Willbold,Antonio Datola,Abhijeet Satwekar,Nadine Barron,Sawako Derosa,Brittany Tomascak,J. W. Dawson,Angelo Palmese,Mara Rossi,Atul Goyal,Binh Vu,Vijay Maranholkar,Ujwal Patil,Katerina Kourentzi,Richard C. Willson,Jelena Šimunović,Jernej Gašperšič,Urh Černigoj,Jana Vidič,Aleš Štrancar,Mislav Novokmet,Genadij Razdorov,Marija Pezer,Gordan Lauc,Irena Trbojević‐Akmačić,Xianglai Li,Nan Li,Mengyuan Zhao,Zhou Zhao,Wenna Li,Xiaolin Shen,Jia Wang,Yajun Yan,Xinxiao Sun,Qipeng Yuan,Takahiro Yukawa,Takahiro Bamba,Mami Matsuda,Takeshi Yoshida,Kentaro Inokuma,Jungyeon Kim,Jae Lee,Yong‐Su Jin,Akihiko Kondo,Tomohisa Hasunuma,R Chen,Li Wan,Yingying Zhu

DOI: https://doi.org/10.1002/bit.28135

IF: 3.8

2023-01-01

Biotechnology and Bioengineering

Abstract:Biotechnology and BioengineeringVolume 120, Issue 2 p. 319-322 ISSUE INFORMATIONFree Access Biotechnology and Bioengineering: Volume 120, Number 2, February 2023 First published: 10 January 2023 https://doi.org/10.1002/bit.28135AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Volume120, Issue2February 2023Pages 319-322 RelatedInformation
Discovery in CRISPR-Cas9 system.

Huali Zhang,Shaowei Pan

DOI: https://doi.org/10.11817/j.issn.1672-7347.2021.210169

2021-12-28

Abstract:The 2020 Nobel Prize in Chemistry was awarded to the American scientist Jennifer A. Doudna and the French scientist Emmanuelle Charpentier, in recognition of their discovery in one of the greatest weapons in genetic technology: CRISPR-Cas9 gene scissors. The CRISPR-Cas system is a bacterial defense immune system against exogenous genetic material. Because the system can specifically recognize and cut DNA, this technology is widely used for precise editing of animal, plant, and microbial DNA. The discovery of CRISPR-Cas9 gene scissors enables the tedious and complicated cell gene editing work to be completed in a few weeks or even less, which has promoted the development of gene editing technology in various fields and brought revolutionary influence to the field of life sciences. At the same time, CRISPR gene editing technology has become one of the new therapies for tumors because of its large number of targets and relatively simple operation, and it also makes gene therapy possible. Although the technology still needs to solve technical problems such as off-target and promoter inefficiency, the CRISPR-Cas system will show its unique advantages in more fields with the continuous development of life science and basic medicine.

Medicine,Chemistry
Biotechnology and Bioengineering: Volume 115, Number 4, April 2018

Geoffrey Liu,Haixia Zhong,Xinling Yang,Yi Liu,Lei,Zhongfan Liu,Anil B. Shrirao,Frederic H. Kung,Alexander Omelchenko,R. P. Schloss,Nada N. Boustany,Jeffrey D. Zahn,Martin L. Yarmush,Bonnie L. Firestein,Peter Westh,Kim Borch,Thomas Lund Sørensen,Radina Tokin,Jameela A. Kari,Silke Flindt Badino,Maria Cristina Cavaleiro,Nanna Røjel,Sören Christensen,Cynthia Segura Vesterager,Corinna Schiano‐di‐Cola,Jae-Cheol Ryou,Young-Jun Sohn,Daekyoung Kim,Hyo Kyeong,Hak Kim,Pavel Dvořák,David Bednář,Pavel Vaňáček,Lukáš Bálek,Lívia Eisellová,Veronika Štěpánková,Eva Šebestová,Michaela Kunova Bosakova,Žaneta Konečná,Stanislav Mazurenko,Antonín Kunka,Tereza Váňová,Karolína Zoufalová,Radka Chaloupková,Jan Brezovský,Pavel Krejčı́,Zbyněk Prokop,Jir̆ı́ Damborský,Substrate Specifi,Eva K. Regel,Tobias Weikert,Anna Niehues,Bruno M. Moerschbacher,R. Paul Singh,John K. Henske,St. Elmo Wilken,Keith R. Solomon,Carol Smallwood,V. Shutthanandan,Jonathan Evans,Marilena Theodorou,Martin O’Malley,Apurba Dey,A. Cupo,Gabriel Ozorowski,Vibha Sharma,Alfredo Behrens,Eden P. Go,Thomas J. Ketas,Anila Yasmeen,P.J. Klasse,Eddy Sayeed,Heather Desaire,Max Crispin,Ian Wilson,R C Sanders,Thomas M. Hassell,Anne Ward,Jason H. Moore,Congcong Du,R. Bruce Martin,Yufei Huang,Ameya U. Borwankar,Zhiming Tang,John E. West,Namrata Singh,Michael Borys,Sanchayita Ghose,Roland Ludwig,Tao Lei,Zhongrui Li,Kang Zhou,Adrian Ionescu,Eric A. Wan,Yuh‐Shan Ho,Carol A. Barnes,Gail E. Christie,Deirdre Wilson,Deise Parolo Tramontin,Pablo Diego Gressler,Linda G. Rorig,Roberto Bianchini Dérner,Jurandir Pereira Filho,Claudemir M. Radetski,Mohatesham Pasha Quadri,Helen L. Ngo,Wenbin Guo,Peng Liao,Xiao Chen,Dong Wang,Yuxiang Pan,Bing‐Jie Ni,Min‐Woo Sa,Binh Minh Nguyen,Robert M. Moriarty,Timur B. Kamalitdinov,John Fisher,J Kim,J Alonso-Gutiérrez,Daisuke Koma,Qiang Hu,Yang,Lingtak‐Neander Chan,Young-Mo Kim,Paul D. Adams,Claudia E. Vickers,Lars K. Nielsen,Jay D. Keasling,T Lee,Abdullah Al Mosabbir,Anam Qudrat,Khai N. Truong,Thomas J. Vogl,Lukas Sturmberger,Pia Fauland,Patrick Hyden,Judith Fischer,Christopher H. Schmid,Gerhard Thallinger,Mark R. Geier,Anton Glieder,Qian Yang,Nils Rehmann,Airong Qian,Ming‐Liang He,P Borys,Z Kayne,Vincenza De Gregorio,Giorgia Imparato,Francesco Urciuolo,Paolo Antonio Netti,Bin Liu,S. Han,Brandon P. Hedrick,Yahya Modarres‐Sadeghi,Michael Lynch,Robert Chen,Hailong Ma,Li Zhang,James D. Bryers

DOI: https://doi.org/10.1002/bit.26416

IF: 3.8

2018-01-01

Biotechnology and Bioengineering

Abstract:US$17114 (US and Rest of World), € 11044 (Europe), £ 8735 (UK
Best Wishes for the Coming Year from the Folks at Bioconjugate Chemistry.

Zhifei Dai,Erin Lavik,Jan van Hest,Gang Zheng,Bradley Smith,Vincent Rotello

DOI: https://doi.org/10.1021/acs.bioconjchem.1c00610

IF: 4.7

2022-01-01

Bioconjugate Chemistry

Abstract:ADVERTISEMENT RETURN TO ISSUEEditorialNEXTBest Wishes for the Coming Year from the Folks at Bioconjugate ChemistryZhifei DaiZhifei DaiMore by Zhifei Dai, Erin LavikErin LavikMore by Erin Lavik, Jan van HestJan van HestMore by Jan van Hest, Gang ZhengGang ZhengMore by Gang Zheng, Bradley SmithBradley SmithMore by Bradley Smith, and Vincent Rotello*Vincent RotelloMore by Vincent RotelloCite this: Bioconjugate Chem. 2022, 33, 1, 1–3Publication Date (Web):January 19, 2022Publication History Published online19 January 2022Published inissue 19 January 2022https://pubs.acs.org/doi/10.1021/acs.bioconjchem.1c00610https://doi.org/10.1021/acs.bioconjchem.1c00610editorialACS PublicationsCopyright © 2022 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views942Altmetric-Citations1LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (4 MB) Get e-AlertscloseSUBJECTS:Chemical biology,COVID-19,Pharmaceuticals,Therapeutics,Vaccination Get e-Alerts
COVID research prizes, CRISPR-like enzymes and a face-mask trial

DOI: https://doi.org/10.1038/d41586-021-02482-x

IF: 64.8

2021-09-15

Nature

Abstract:Nature, Published online: 15 September 2021; doi:10.1038/d41586-021-02482-xThe latest science news, in brief.

multidisciplinary sciences
The Myriad Decision at 10

Jacob S Sherkow,Robert Cook-Deegan,Henry T Greely,Jacob S. Sherkow,Henry T. Greely

DOI: https://doi.org/10.1146/annurev-genom-010323-011239

2024-02-29

Annual Review of Genomics and Human Genetics

Abstract:A decade ago, the US Supreme Court decided Association for Molecular Pathology v. Myriad Genetics, Inc., concluding that isolated genes were not patentable subject matter. Beyond being a mere patent dispute, the case was a political and cultural phenomenon, viewed as a harbinger for the health of the biotechnology industry. With a decade of perspective, though, Myriad’s impact seems much narrower. The law surrounding patentable subject matter—while greatly transformed—only centered on Myriad in small part. The case had only a modest impact on patenting practices both in and outside the United States. And persistent efforts to legislatively overturn the decision have not borne fruit. The significance of Myriad thus remains, even a decade later, hidden by larger developments in science and law that have occurred since the case was decided. Expected final online publication date for the Annual Review of Genomics and Human Genetics, Volume 25 is August 2024. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.

genetics & heredity
Biotechnology and Bioengineering: Volume 115, Number 10, October 2018

Zhiqiang Du,Jian‐Jiang Zhong,Bingming Ou,Carolina Garcia,Yejun Wang,Weiping Zhang,Guoqiang Articles,Roland Prielhofer,Michaela Reichinger,Nina Wagner,Katrien Claes,Christoph Kiziak,Brigitte Gasser,Diethard Bioseparations,Daniel G. Greene,Steven J. Traylor,Jun Guo,Leila H. Choe,Shannon Modla,Xuankuo Xu,Namrata Singh,Lye T. Lock,Sanchayita Ghose,Jian Zheng,Kelvin Li,Norman Lee,Abraham R. Wagner,Review Lenhoff,Sultan Khetani,Mehdi Mohammadi,Amir Sanati Nezhad,Sylvain Prigent,Jens Nielsen,Jens Christian Frisvad,Joseph T. Decker,Matthew S. Hall,Rachel Blaisdell,Kallen Schwark,Jacqueline S. Jeruss,Lonnie D. Shea,Patrick Kaiser,Melanie Werner,Valérie Jérôme,Ruth Freitag,Annika Wenz,Iva Tjoeng,Isabelle Schneider,Petra J. Kluger,Kirsten Borchers,Akhil Patel,Yuanyuan Xue,Rebecca Hartley,Vinayak Sant,James R. Eles,Xinyan Tracy Cui,Donna B. Stolz,Shilpa Sant

DOI: https://doi.org/10.1002/bit.26428

IF: 3.8

2018-01-01

Biotechnology and Bioengineering

Abstract:right asymmetry in tissue microarchitectures.To investigate this phenomenon, fl uorescence staining of nuclei was used to reveal such orientation,
Biotechnology and Bioengineering: Volume 120, Number 5, May 2023

Yusuf Sürmeli,Gülşah Şanlı‐Mohamed,Saxena Nikita,Somesh Mishra,Keshari Gupta,Venkataramana Runkana,James Gomes,Anurag S. Rathore,Tuyelee Das,Uttpal Anand,Tarun Pal,Sayanti Mandal,Manoj Kumar,Abilash Valsala Gopalakrishnan,J.P. Marques de,La Lastra,Abhijit Dey,Elisa Mele,Ho‐Joon Lee,Ju Hyoung Mun,Cho‐Rok Jung,Hyun‐Mi Kang,Jae‐Eun Kwon,Jae‐Sung Ryu,Hyo‐Suk Ahn,Ok‐Seon Kwon,Junho Ahn,Kyung-Sik Moon,Marion O. Son,Kyung‐Sook Chung,Mehwish Arshad,Shuyu Cheng,Maarten van Reeuwijk,Spencer J. Sherwin,Peter D. Weinberg,Patrick Bongartz,Tobias Karmainski,Moritz Meyer,John Linkhorst,Till Tiso,Lars M. Blank,Matthias Weßling,Heiko Steinhoff,Maurice Finger,Michael Osthege,Corinna Golze,Simone Schito,Stephan Noack,Jochen Büchs,Alexander Grünberger,Lukas M. Trebuch,Kobe Schoofs,Stijn M. F. Vaessen,Thomas R. Neu,Marcel Janssen,René H. Wijffels,L.E.M. Vet,Tânia R. Fernandes,Zhuoshi Du,Kanwaldeep Gill,Vishal M. Toprani,Andrew L. Zydney,Xu Chen,Benjamin Frigo‐Vaz,Joshua Goering,Ping Wang,Yuxin Tang,Baolong Zhang,Zhaoyang Li,Ping Deng,Xuan Deng,Huan Long,Xun Wang,Kaiyao Huang,Mul Ple,Jiaqi Liu,Xiaoqian Ma,Dongfeng Liu,Chengao Yang,Dao‐Bo Li,Di Min,Han-Qing Yu,Shiori Saito,Masahiro Nishihara,Masato Kohakura,Kosuke Kimura,Takuya Yashiro,Seidai Takasawa,Gen‐ichiro Arimura,Eric VanArsdale,Ali Navid,Monica W. Chu,Tiffany M. Halvorsen,Gregory F. Payne,Yongqin Jiao,William E. Bentley,Mimi C. Yung,Carlos H. Luna‐Flores,Alexander Wang,Zhenling Cui,Juhani von Hellens,Robert Speight,Delaney Sanborn,Ruichen He,Feng Liu,Jiarong Hong,Yawei Shi,Jinyao Zhang,Zheng Ma,Yongyong Zhang,Andreas Bechthold,Xiaoping Yu,Wenrui Zhang,Wei Lu,Kexin Sun,Haiyue Jiang,Shoshana Bloom,Nicholas O'hare,Neil Forbes

DOI: https://doi.org/10.1002/bit.28138

IF: 3.8

2023-01-01

Biotechnology and Bioengineering

Abstract:Biotechnology and BioengineeringVolume 120, Issue 5 p. 1167-1170 ISSUE INFORMATIONFree Access Biotechnology and Bioengineering: Volume 120, Number 5, May 2023 First published: 12 April 2023 https://doi.org/10.1002/bit.28138AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Volume120, Issue5May 2023Pages 1167-1170 RelatedInformation

Row over Curie building ends on a high note

A New Horizon in Engineering: Introducing Chem & Bio Engineering

Biotech news from around the world

Biotechnology and Bioengineering: Volume 112, Number 8, August 2015

The Ever-Expanding Boundaries of Synthetic Biology.

Sanofi- Cell Research outstanding paper award of 2023

Single-cell biology: what does the future hold?

CRISPR Nobelists surrender their own European patents

Erratum: Nature Biotechnology's academic spinouts of 2017

Chemistry Nobel Honors CRISPR, an "Essential" Tool for Cancer.

Biotechnology Patent Law Top Ten of 2022: Inducement, Clear Error, and Interferences Galore

Editor's pick: Tome Biosciences

What Will We Carry Forward from This Time?

Biotechnology and Bioengineering: Volume 120, Number 2, February 2023

Discovery in CRISPR-Cas9 system.

Biotechnology and Bioengineering: Volume 115, Number 4, April 2018

Best Wishes for the Coming Year from the Folks at Bioconjugate Chemistry.

COVID research prizes, CRISPR-like enzymes and a face-mask trial

The Myriad Decision at 10

Biotechnology and Bioengineering: Volume 115, Number 10, October 2018

Biotechnology and Bioengineering: Volume 120, Number 5, May 2023